Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

80 results about "Chicoric acid" patented technology

Chicoric acid is a caffeic acid derivative, belonging to the group of polypfenols. Chicoric acid is the most active compound in Echinacea pupurea.

Echinacea extract and preparation method of echinacea extract

The invention relates to an echinacea extract and a preparation method of the echinacea extract. The echinacea extract provided by the invention is obtained through carrying out twice extraction on echinacea medicinal materials by alkaline ethanol solution and lysozyme; and in the product, the polysaccharide content is greater than or equal to 21.50 percent, the polyphenol content is greater than or equal to 8.10 percent, and the chicoric acid content is greater than equal to 5.00 percent. Because the polyphenol content and the chicoric acid content of the echinacea extract are obviously increased, the echinacea extract is prepared into ordinary preparations including powder or oral liquid and the like, and the curative effect is greatly improved. In a compound preparation processed by the echinacea extract and bacteriolysant according to a consumption ratio being 3:1, active ingredients of echinacea and lysozyme totally account for 20 percent, wherein the consumption ratio of the echinacea extract to the lysozyme is (4-1):1, auxiliary materials of cane sugar account for 64 percent, and dextrin accounts for 16 percent. The compound preparation has the functions of improving the immunity of live stock and realizing the sterilization and antivirus functions, and can be used as medicine for preventing and treating animal diseases, particularly chicken diseases caused by escherichia coli infection.
Owner:QILU ANIMAL HEALTH PROD

Echinacea purpurea extract and preparing method and phenols ingredient detection method thereof

The present invention discloses an echinacea purpurea extract. The echinacea purpurea extract comprises 2.4 to 3.1% of caftaric acid, 4.4 to 5.7% of chicoric acid and 1.5 to 2.0% of echinacoside based on the weight percentages of all ingredients accounting for the dry weight of the extract. The present invention also discloses a preparing method of echinacea purpurea extract and a detection method for phenols ingredient content in echinacea purpurea extract. The phenols ingredient content in the echinacea purpurea extract all meet the requirements of the active ingredient content specification of echinacea purpurea in United State Pharmacopeia 30 (USP 30). The phenols ingredient content is increased by 4 to 6% than that of echinacea purpurea extract sold on market. The preparing method has the advantages of simple technique, low cost, low energy consumption and easy industrialization.
Owner:上海雷允上科技发展有限公司 +1

Synthesis method of (-)-chicoric acid

The invention relates to a synthesis method of (-)-chicoric acid, which comprises the following steps: reacting diacetylcaffeic acid with (L)-tartaric acid in the presence of thionyl chloride or oxalyl chloride to obtain (-)-tetraacetylchicoric acid; or reacting diacetylcaffeic acid with thionyl chloride to obtain diacetyl caffeic acyl chloride, and reacting with (L)-tartaric acid to obtain the (-)-tetraacetylchicoric acid; and finally, removing acetyl group in the (-)-tetraacetylchicoric acid in a mixed solution of an acid solution and a water-soluble organic solvent, thereby obtaining the (-)-chicoric acid. By removing the steps of tartaric acid carboxyl protection and deprotection, the invention has the advantage of simple synthesis technique, and is economical and practical.
Owner:HUNAN NORMAL UNIVERSITY

QAMS for detecting content of organic acids in sowthistle-leaf ixeris seedling injection

InactiveCN104502502AQuality assuranceChromatographic peak positioning is easy and feasibleComponent separationOrganic acidChlorogenic acid
The invention relates to the field of analysis of traditional Chinese medicine components, and relates to QAMS for detecting the content of organic acids in sowthistle-leaf ixeris seedling injection. The QAMS disclosed by the invention comprises the following steps: (1), setting chromatographic conditions; (2), preparing a reference solution; (3), preparing a test solution; and (4), calculating correction factors. Relative correction factors of chicoric acid, mono-caffeoyl tartaric acid, chlorogenic acid and caffeic acid are calculated by taking chicoric acid as the internal reference compound, and used as constants for detecting the content; correction factors are calculated by taking effective active components in the sowthistle-leaf ixeris seedling injection and high-content chicoric acid as internal reference compounds; the content of mono-caffeoyl tartaric acid, chlorogenic acid and caffeic acid in the sowthistle-leaf ixeris seedling injection are calculated; the content of the four organic acids in the injection can be detected simultaneously; therefore, the quality of the sowthistle-leaf ixeris seedling injection in industrial production can be monitored scientifically, sensitively and rapidly; and simultaneously, the problem that the quality of the sowthistle-leaf ixeris seedling injection cannot be controlled objectively and reasonably because of shortage of reference substances can be solved.
Owner:TONGHUA HUAXIA PHARMA

Use of chicoric acid and derivatives for regulating skin pigmentation

The present invention relates generally to the field of food products for cosmetic purpose. More specifically, the present invention aims to provide an ingredient containing chicoric acid and / or derivatives for preventing and / or treating hyper-pigmentation of skin, skin color imperfections such as age-spots and other skin disorders characterized by abnormal pigments. The present invention also aims at improving skin tone as well as providing a skin lightening agent.
Owner:SOC DES PROD NESTLE SA

Injection-grade echinacea extractive and injection thereof

The invention relates to an injection-grade echinacea extractive and an injection thereof. The extractive is prepared according to the following method: 1) crushing echinacea for usage; 2) warmly dipping the crushed echinacea powder with an aqueous solution containing a base to extract for two times, filtering, discarding medicine residues, and merging the filtrate for usage; 3) applying the filtrate obtained in the step 2) to anion resin, washing with water, then eluting with an ethanol solution containing an acid, collecting the eluate, and recovering ethanol in a reduced-pressure manner, and obtaining a concentrate for usage; and 4) performing salting out on the concentrate obtained in the step 3), refrigerating, filtering, discarding filtrate, and washing the precipitate with water, so as to obtain the extractive. The provided injection is high in content of intermediates chicoric acid and caftaric acid, low in cost and good in medicine effect.
Owner:QINGDAO VLAND BIOTECH INC

Method of augmenting the immune-modulatory activity of standardized Echinacea preparations

Echinacea preparations having standardized chicoric acid levels and inducing an augmented level of immune-stimulatory activity. Augmentation of the immune stimulatory activity is achieved by the selection of a harvest time for Echinacea plants that is during a plant maturation stage that is prior to full bloom. Methods for augmenting the immune-stimulatory effects of Echinacea extracts by harvesting Echinacea plants prior to full bloom.
Owner:ACCESS BUSINESS GRP INT LLC

Application of chicoric acid in preparation of medicament for treating obesity or complications thereof

ActiveCN110327323AEffective weight regulationEffectively regulate blood lipid levelsOrganic active ingredientsMetabolism disorderHigh fatBlood lipids
The invention discloses application of chicoric acid in preparation of a medicament or a health product for treating obesity or complications thereof. The invention expands the application range of the chicoric acid, and the chicoric acid can effectively regulate the body weight and the blood fat level of a high-fat model mouse, improve the kidney function and reduce renal tubular injury.
Owner:INST OF BOTANY JIANGSU PROVINCE & CHINESE ACADEMY OF SCI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products